(1 - 13 from 17
)
Roche says Avastin ovary cancer data substantial - Reuters
www.reuters.com
May 21, · "In ovarian cancer, we are presenting substantial results," Dr. Mondher Mahjoubi, head of global product strategy oncology and director of medical affairs ...
UPDATE 1-Avastin helps in ovarian cancer but effects fade
www.finanznachrichten.de
Mondher Mahjoubi, Roche's head of oncology, said ovarian cancer could add between 500 million Swiss francs and 1 billion ($500 million to $1 billion)
Un nuovo farmaco aumenta il successo del trattamento chirurgico ...
www.molecularlab.it
Il dottor Mondher Mahjoubi Global Head Medical Affairs Oncology di Roche ha spiegato: 'La resezione completa delle lesioni metastatiche è l'unica possibilità di guarigione per i pazienti affetti da carcinoma colon-rettale ...
AstraZeneca Initiates CDx Partnerships with Roche, Qiagen
www.genengnews.com
Pharma will co-develop diagnostics for two NSCLC drugs, investigational compound AZD9291 and EC-approved Iressa
sorted by relevance / date